Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.
Substitution pathways 🇦🇺 Australia · TGA
—
No substitution instrument in force
Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.
Shortage status by regulator official notices
🇨🇦
Canada
Medsafe NZ Full · 3mo ago
High
🇨🇭
Switzerland
Swissmedic · 2d ago
Medium
Recalls official enforcement reports
🇨🇦
YERVOY 200 mg/40 mL (5 mg/mL) (Ipilimumab for injection
Generated 4 July 2026 · Australia market · 2 regulatory sources
For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.